•In this study, hearts from 72 male Wistar albino rats were divided into two main protocols: a 40 min ischemia group (protocol A, n = 53) and 10 min ischemia group (protocol B, n = 19). Protocol A subdivided into 2 groups as a control group (n = 10) and adrenaline group (n = 43). Protocol B is subdivided into 2 groups as control group (n = 10) and adrenaline group (n = 9). Both adrenaline groups received the same dose of adrenaline.•In protocol A, ventricular tachyarrhythmia (VTA) incidence was 0 % in controls but rose to 72 % in the adrenaline group (p < 0.01). Heart rates for the control and adrenaline groups in stabilization and reperfusion were 254±45 bpm and 247 ± 66 bpm, versus 277 ± 41 bpm and 651 ± 286 bpm, respectively.•In protocol B, VTA incidence reached 100 % in both groups during reperfusion, with heart rates of 393 ± 29 bpm and 892±227 bpm for controls and 350 ± 49 bpm and 949 ± 116 bpm for the adrenaline group.•These findings suggest that direct adrenaline administration into the heart in last 5 mins of the ischemic period and the 5 mins of in the reperfusion time increases the incidence of reperfusion-induced ventricular arrhythmias up to 72 % in protocol A. Protocol B hearts showed reperfusion-induced ventricular arrhythmias with 100 % incidence in both groups.

Department of Chemical Drugs Faculty of Pharmacy Masaryk University Brno Czech Republic

Department of Internal Cardio angiology Faculty of Medicine Masaryk University Brno Czech Republic

Department of Internal Cardiology Faculty of Medicine Masaryk University Brno Czech Republic

Department of Paediatric Oncology Faculty of Medicine Masaryk University Brno Czech Republic

Department of Pharmacology and Toxicology Faculty of Pharmacy Masaryk University Brno Czech Republic

Department of Pharmacology Pharmacy Faculty University of Costa Rica San Pedro Costa Rica

Faculty of Chemistry Rzeszow University of Technology Rzeszow Poland

International Clinical Research Centre St Anne's University Hospital Brno Czech Republic

Zobrazit více v PubMed

Vidavalur R., Swarnakar S., Thirunavukkarasu M., Samuel S.M., Maulik N. Ex vivo and In vivo approaches to study mechanisms of cardioprotection targeting ischemia/reperfusion (I/R) injury: useful techniques for cardiovascular drug discovery. Curr. Drug. Discov. Technol. 2008;5(4):269–278. PubMed

Neckář J., Alánová P., Olejníčková V., Papoušek F., Hejnová L., Šilhavý J., et al. Excess ischemic tachyarrhythmias trigger protection against myocardial infarction in hypertensive rats. Clin. Sci. 2021;135(17):2143–2163. PubMed

Lindsey M.L., Bolli R., Canty J.M., Jr, Du X.J., Frangogiannis N.G., Frantz S., Gourdie R.G., Holmes J.W., Jones S.P., Kloner R.A., Lefer D.J., Liao R., Murphy E., Ping P., Przyklenk K., Recchia F.A., Schwartz Longacre L., Ripplinger C.M., Van Eyk J.E., Heusch G. Guidelines for experimental models of myocardial ischemia and infarction. Am. J. Physiol. Heart Circ. Physiol. 2018;314(4):H812–H838. PubMed PMC

Al-Awar A., Almási N., Szabó R., Takacs I., Murlasits Z., Szűcs G., et al. Novel potentials of the DPP-4 inhibitor sitagliptin against ischemia-reperfusion (I/R) injury in rat ex-vivo heart model. Int. J. Mol. Sci. 2018;19(10):3226. PubMed PMC

Curtis M.J. Characterisation, utilisation and clinical relevance of isolated perfused heart models of ischaemia-induced ventricular fibrillation. Cardiovasc. Res. 1998;39(1):194–215. PubMed

Marshall R.J., Muir A.W., Winslow E. Development of a severe model of early coronary artery ligation-induced dysrhythmias in the anaesthetized rat. Br. J. Pharmacol. 1981;73(4):951–959. PubMed PMC

Farkas A., Curtis M.J. Limited antifibrillatory effectiveness of clinically relevant concentrations of class I antiarrhythmics in isolated perfused rat hearts. J. Cardiovasc. Pharmacol. 2002;39(3):412–424. PubMed

Manning A.S., Kinoshita K., Buschmans E., Coltart D.J., Hearse D.J. The genesis of arrhythmias during myocardial ischemia. Dissociation between changes in cyclic adenosine monophosphate and electrical instability in the rat. Circ. Res. 1985;57(5):668–675. PubMed

Stables C.L., Curtis M.J. Development and characterization of a mouse in vitro model of ischaemia-induced ventricular fibrillation. Cardiovasc. Res. Volume. 2009;83(2):397–404. PubMed

Bernier M., Curtis M.J., Hearse D.J. Ischemia-induced and reperfusion-induced arrhythmias: importance of heart rate. Am. J. Physiol. 1989;256(1 Pt 2):H21–H31. PubMed

Schneider C.A., Rasband W.S., Eliceiri K.W. NIH image to ImageJ: 25 years of image analysis. Nat. Methods. 2012;9(7):671–675. PubMed PMC

Curtis M.J., Hancox J.C., Farkas A., Wainwright C.L., Stables C.L., Saint D.A., et al. The Lambeth Conventions (II): guidelines for the study of animal and human ventricular and supraventricular arrhythmias. Pharmacol. Therap. 2013;139(2):213–248. PubMed

Schömig A., Dart A.M., Dietz R., Mayer E., Kübler W. Release of endogenous catecholamines in the ischemic myocardium of the rat. Part A: locally mediated release. Circ. Res. 1984;55(5):689–701. PubMed

Jalife J. Ventricular fibrillation: mechanisms of initiation and maintenance. Annu. Rev. Physiol. 2000;62:25–50. PubMed

Waks J.W., Josephson M.E. Mechanisms of atrial fibrillation - reentry, rotors and reality. Arrhythm. Electrophysiol. Rev. 2014;3(2):90–100. PubMed PMC

Hundahl L.A., Tfelt-Hansen J., Jespersen T. Rat models of ventricular fibrillation following acute myocardial infarction. J. Cardiovasc. Pharmacol. Ther. 2017;22(6):514–528. PubMed

Akar J.G., Akar F.G. Regulation of ion channels and arrhythmias in the ischemic heart. J. Electrocardiol. 2007;40(6 Suppl):S37–S41. PubMed

Hausenloy D.J., Yellon D.M. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J. Clin. Invest. 2013;123(1):92–100. PubMed PMC

Hearse D.J. Reperfusion-induced injury: a possible role for oxidant stress and its manipulation. Cardiovasc. Drugs Ther. 1991;5(Suppl 2):225–235. PubMed

Murphy E., Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol. Rev. 2008;88(2):581–609. PubMed PMC

Clements-Jewery, H. and Curtis, M.J. (2014). The Langendorff Preparation. In Manual of Research Techniques in Cardiovascular Medicine (eds H. Ardehali, R. Bolli and D.W. Losordo).

Curtis M.J., Hearse D.J. Ischaemia-induced and reperfusion-induced arrhythmias differ in their sensitivity to potassium: implications for mechanisms of initiation and maintenance of ventricular fibrillation. J. Mol. Cell Cardiol. 1989;21(1):21–40. PubMed

Dai W., Amoedo N.D., Perry J., Le Grand B., Boucard A., Carreno J., et al. Effects of OP2113 on myocardial infarct size and No reflow in a rat myocardial ischemia/reperfusion model. Cardiovasc. Drugs Ther. 2022;36(2):217–227. PubMed

Kohn JS Michael. Proportions – Effect size | sample size calculators [Internet]. [cited 2024 Feb 27]. Available from: https://sample-size.net/proportions-effect-size/.